A recently completed international multi-center clinical trial has found that acyclovir, a drug widely used as a safe and effective treatment to suppress herpes simplex virus-2 (HSV-2), which is the most common cause of genital herpes, does not reduce the risk of HIV transmission when taken by people infected with both HIV and HSV-2.

HIV cases are rising rapidly in China, especially among gay men, and AIDS is now the leading cause of death among infectious diseases on the mainland.

Researchers at Northwestern University have discovered a critical new way a man can transmit the HIV virus to a woman.

A new study published in Lancet's current issue says that if people in the developing countries that have high rates of HIV and AIDS can be regularly tested and checked the HIV infection can be eliminated in a decade. The AIDS and HIV treatment experts from the World Health Organization say it's quite startling to see this happening in ten years.

Despite ongoing efforts to educate the public about HIV, a new study by researchers from UCLA, the RAND Corp., Harvard University and Children's Hospital Boston has found that two-thirds of families with an HIV-infected parent experience fears about spreading HIV in the home.

The links between HIV transmission and the degree to which people are able to adopt realistic plans to achieve future projects, in other words, hope, have been overlooked in policies to tackle HIV/AIDS. New research funded by the Economic and Social Research Council (ESRC) argues that hope is a powerful tool in the battle to stop the spread of HIV/AIDS.

Approximately half of all new HIV infections in the United States result from the sexual risk behaviors of men who have sex with men. Now, a new study led by a researcher at The Miriam Hospital provides additional insight into which of these men are most likely to transmit HIV to others, potentially paving the way for the development of more targeted prevention programs.

Contrary to the belief that HIV-infected injection drug users (IDUs) receive less benefit from highly active antiretroviral therapy (HAART), new research finds little difference in the survival rate between IDUs and non-IDUs after 4-5 years of receiving HAART, according to a study in the August 6 issue of JAMA, a theme issue on HIV/AIDS.

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), is reshaping its research enterprise to broaden HIV vaccine discovery activities.

Researchers from Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) found that sexual behavior counseling during drug addiction treatment should be considered an important component among Russian substance-dependent individuals, in order to decrease risky sexual behavior in the HIV at-risk population.

Acquired Immune Deficiency Syndrome (AIDS) is a global epidemic threatening the lives of millions of people. Because there is no known cure, prevention of the transmission of the virus that causes AIDS, the Human Immunodeficiency Virus (HIV), is critical for controlling the disease.

The issue of early testing of HIV is not only important here in Malawi, but everywhere. The NY City Department of Health is starting a push to expand HIV testing in the Bronx.